Due to its association with tumour invasiveness and the fact that it is consistently overexpressed from the earliest to the latter stages of colorectal carcinogenesis, AQP1 is now considered a poor predictive biomarker of patient survival [27, 28]. The gene discussed is AQP1; the disease is neoplasm.